GlassScriptPhysician profile
Shalini Singh
NPI 1275534208
$2,364.20
in general payments reported to CMS, 2019-2025
28 companies · $704 in 2025
The $704 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $360 · 2021: $62.80 · 2022: $168 · 2023: $286 · 2024: $531 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $546.94 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $277.01 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $267.16 | 2019-2022 | |
| Pfizer INC. | $206.25 | 2022-2025 | |
| Glaxosmithkline, LLC. | $160.56 | 2019-2025 | Trelegy Ellipta |
| Amgen INC. | $129.37 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.94 | 2020-2025 | Jardiance |
| Abbott Laboratories | $70.85 | 2022-2025 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $52.34 | 2020-2024 | Heplisav-B |
| Cranial Technologies, INC | $48.03 | 2019-2025 | Doc Band |
| Dexcom, INC. | $45.88 | 2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $44.63 | 2025 | Korlym |
| Lilly USA, LLC | $41.30 | 2025 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $40.26 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.74 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $30.63 | 2019-2020 | |
| Exact Sciences Corporation | $29.52 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $24.62 | 2025 | Thinprep 2000 Processor, Aptima |
| Olympus America INC. | $23.74 | 2025 | Itind System |
| Avadel Cns Pharmaceuticals, LLC | $23.05 | 2025 | Lumryz |
| Astellas Pharma US INC | $22.35 | 2023 | Veozah |
| Otsuka America Pharmaceutical, INC. | $21.38 | 2025 | Rexulti |
| Harmony Biosciences LLC | $20.81 | 2023 | Wakix |
| Sanofi Pasteur INC. | $19.47 | 2019 | |
| Inari Medical, INC. | $16.02 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ultragenyx Pharmaceutical INC. | $14.47 | 2024 | Crysvita |
| Rgh Enterprises LLC | $13.71 | 2025 | |
| Allergan, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalini Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.